日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Understanding exceptional response: The role of MINDY1 SNP in CDK4/6 inhibitor therapy for ER(+), HER2(-) advanced breast cancer

了解卓越疗效:MINDY1 SNP 在 CDK4/6 抑制剂治疗 ER(+)、HER2(-) 晚期乳腺癌中的作用

Balla, Eleni; Li, Yi; Zhou, Zikun; Nguyen, John T; Papadopoulou, Kyriaki; Razis, Evangelia; Koutras, Angelos; Galani, Eleni; Mountzios, Giannis; Romanidou, Ourania; Fountzilas, George; Christopoulou, Athina; Tryfonopoulos, Dimitris; Oikonomopoulou, Panagiota; Saridaki, Zenia; Koumarianou, Anna; Fountzilas, Elena; Bleris, Leonidas

The Impact of Lifestyle Medicine on Quality of Life in Female Breast Cancer Survivors: A Systematic Review

生活方式医学对女性乳腺癌幸存者生活质量的影响:系统评价

Charalampopoulou, Maria; Tamiolaki, Evangelia E; Tryfonopoulos, Dimitrios; Bletsa, Garyfalia; Tsakogiannis, Dimitrios; Tzioga, Lamprini; Bacopoulou, Flora; Darviri, Christina; Zagouri, Flora; Zografos, George C

Real-World Toxicity and Effectiveness Study of Abemaciclib in Greek Patients with Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: A Multi-Institutional Study

阿贝西利在希腊激素受体阳性/人表皮生长因子受体2阴性乳腺癌患者中的真实世界毒性和有效性研究:一项多中心研究

Fountzilas, Elena; Aravantinou-Fatorou, Eleni; Dadouli, Katerina; Economopoulou, Panagiota; Tryfonopoulos, Dimitrios; Vernadou, Anastasia; Vorrias, Eleftherios; Vagionas, Anastasios; Nikolaidi, Adamantia; Karageorgopoulou, Sofia; Koumarianou, Anna; Boukovinas, Ioannis; Mauri, Davide; Kokkali, Stefania; Christopoulou, Athina; Tsoukalas, Nikolaos; Assi, Avraam; Spathas, Nikolaos; Kosmidis, Paris; Koutras, Angelos; Fountzilas, George; Psyrri, Amanda

Real-world management strategies and clinical outcomes of metastatic HER2-positive breast cancer in Greece in the second-line setting and beyond (the togetHER study)

希腊转移性 HER2 阳性乳腺癌二线及后续治疗的真实世界管理策略和临床结果(togetHER 研究)

Korantzis, Ippokratis; Koumarianou, Anna; Rapti, Vassiliki; Timotheadou, Eleni; Christodoulou, Christos; Tryfonopoulos, Dimitrios; Karageorgopoulou, Sofia; Boukovinas, Ioannis; Zagouri, Flora; Nikolaidi, Adamantia; Papazisis, Konstantinos; Razis, Evangelia; Barbounis, Vasileios; Christopoulou, Athina; Mavroudis, Dimitrios; Georgoulias, Vassilios; Kesisis, Georgios; Papadopoulos, Emmanuel I; Michalea, Rozalia; Ardavanis, Alexandros

Real-world safety and effectiveness data of trastuzumab deruxtecan and sacituzumab govitecan in breast cancer: a Hellenic Cooperative Oncology Group study

曲妥珠单抗德鲁西替康和沙妥珠单抗戈维替康在乳腺癌中的真实世界安全性和有效性数据:一项希腊肿瘤协作组研究

Fountzilas, E; Karageorgopoulou, S; Karakatsoulis, G; Tryfonopoulos, D; Papazisis, K; Koutras, A; Koumarianou, A; Zafeiri, G; Biziota, E; Nikolaidi, A; Boukovinas, I; Vrana, E; Mauri, D; Aravantinou-Fatorou, E; Razis, E; Vorrias, E; Saridaki, Z; Bafaloukos, D; Christopoulou, A; Boutis, A; Tsoukalas, N; Stamatopoulou, S; Spathas, N; Theochari, M; Zagouri, F; Psyrri, A; Fountzilas, G; Lalla, E

Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes

对极早发性乳腺癌(≤30岁)患者进行基因检测,发现其携带高比例的种系致病性变异,主要集中在BRCA1、TP53和BRCA2基因。

Apostolou, Paraskevi; Dellatola, Vasiliki; Papathanasiou, Athanasios; Kalfakakou, Despoina; Fountzilas, Elena; Tryfonopoulos, Dimitrios; Karageorgopoulou, Sofia; Yannoukakos, Drakoulis; Konstantopoulou, Irene; Fostira, Florentia

CDK4/6 and aromatase inhibitors as first-line treatment in metastatic high-grade neuroendocrine carcinoma of the breast: A case report

CDK4/6 和芳香化酶抑制剂作为转移性高级别乳腺神经内分泌癌的一线治疗:病例报告

Zouki, Dionysia N; Kardara, Vasiliki-Elpida; Ioannou, Stephanie; Arvanitou, Eleni; Exarchos, Konstantinos; Gkikas, Konstantinos; Konstantoudakis, Stefanos; Lanitis, Sophocles; Benakis, Stylianos; Tryfonopoulos, Dimitrios

Characteristics and outcomes of cancer patients who develop pulmonary embolism: A cross-sectional study

癌症患者发生肺栓塞的特征和预后:一项横断面研究

Chlapoutakis, Serafeim; Georgakopoulou, Vasiliki Epameinondas; Trakas, Nikolaos; Kouvelos, Georgios; Papalexis, Petros; Damaskos, Christos; Sklapani, Pagona; Grivas, Anastasios; Gouveris, Panagiotis; Tryfonopoulos, Dimitrios; Tzovaras, Alexandros; Ardavanis-Loukeris, Gerasimos; Grouzi, Elissavet; Spandidos, Demetrios A; Matsagkas, Miltiadis

Real-world clinical outcome and toxicity data and economic aspects in patients with advanced breast cancer treated with cyclin-dependent kinase 4/6 (CDK4/6) inhibitors combined with endocrine therapy: the experience of the Hellenic Cooperative Oncology Group

希腊合作肿瘤组(Hellenic Cooperative Oncology Group)的经验:采用细胞周期蛋白依赖性激酶4/6 (CDK4/6) 抑制剂联合内分泌治疗晚期乳腺癌患者的真实世界临床疗效、毒性数据及经济效益分析

Fountzilas, Elena; Koliou, Georgia-Angeliki; Vozikis, Athanassios; Rapti, Vassiliki; Nikolakopoulos, Achilleas; Boutis, Anastasios; Christopoulou, Athina; Kontogiorgos, Ioannis; Karageorgopoulou, Sofia; Lalla, Efthalia; Tryfonopoulos, Dimitrios; Boukovinas, Ioannis; Rapti, Cleopatra; Nikolaidi, Adamantia; Karteri, Sofia; Moirogiorgou, Evangelia; Binas, Ioannis; Mauri, Davide; Aravantinos, Gerasimos; Zagouri, Flora; Saridaki, Zacharenia; Psyrri, Amanda; Bafaloukos, Dimitrios; Koumarianou, Anna; Res, Eleni; Linardou, Helena; Mountzios, Giannis; Razis, Evangelia; Fountzilas, George; Koumakis, Georgios

Pilot study of bevacizumab in combination with docetaxel and cyclophosphamide as adjuvant treatment for patients with early stage HER-2 negative breast cancer, including analysis of candidate circulating markers of cardiac toxicity: ICORG 08-10 trial

一项针对早期 HER-2 阴性乳腺癌患者的辅助治疗方案的贝伐珠单抗联合多西他赛和环磷酰胺的试点研究,包括对心脏毒性候选循环标志物的分析:ICORG 08-10 试验

Gullo, Giuseppe; J Eustace, Alex; Canonici, Alexandra; M Collins, Denis; Kennedy, Michael J; Grogan, Liam; Breathhnach, Oscar; McCaffrey, John; Keane, Maccon; Martin, Michael J; Gupta, Rajnish; Leonard, Gregory; O'Connor, Miriam; Calvert, Paula M; Donnellan, Paul; Walshe, Janice; McDermott, Enda; Scott, Kathleen; Hernando, Andres; Parker, Imelda; W Murray, David; C O'Farrell, Alice; Maratha, Ashwini; Dicker, Patrick; Rafferty, Mairin; Murphy, Verena; O'Donovan, Norma; M Gallagher, William; Ky, Bonnie; Tryfonopoulos, Dimitrios; Moulton, Brian; T Byrne, Annette; Crown, John